Literature DB >> 1263725

Tuberculosis of the larynx.

L W Travis, R L Hybels, M H Newman.   

Abstract

Tuberculosis of the larynx, once a common disease, has become quite rare with the advent of anti-tuberculous chemotherapy. In the pre-antibiotic era two modes of laryngeal infection were recognized; bronchogenic and hematogenous. The literature is briefly reviewed. Thirteen patients in the past 15 years in whom tuberculous laryngitis was diagnosed upon indirect laryngoscopy by members of the University of Michigan Department of Otorhinolaryngology are presented. Bronchogenic infection was present in 11, and in two patients the disease was consistent with hematogenous spread. Tissue biopsy from a case of bronchogenic contamination demonstrated epithelioid tubercles, while numerous subepithelial acid-fast bacilli without typical tuberculous histological change were present in a case of hematogenous laryngeal infection. A case of cicatricial laryngeal stenosis was successfully treated surgically by laryngofissure, excision of fibrosis with arytenoidectomy, and free mucous membrane grafting. Finally, the initial subtle presentation of many of our patients emphasizes the importance of a consideration of tuberculosis in the differential diagnosis of chronic laryngitis.

Entities:  

Mesh:

Year:  1976        PMID: 1263725     DOI: 10.1288/00005537-197604000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Laryngeal tuberculosis: a case report.

Authors:  C E Jones; B D Jones
Journal:  J Natl Med Assoc       Date:  1979-01       Impact factor: 1.798

2.  Case Report: Acute tuberculous laryngitis presenting as acute epiglottitis.

Authors:  Ahmed H El Beltagi; Pushpinder S Khera; Lamya Alrabiah; Noufa F J Al Shammari
Journal:  Indian J Radiol Imaging       Date:  2011-10

3.  Intravital Fluorescence Excitation in Whole-Animal Optical Imaging.

Authors:  Fatemeh Nooshabadi; Hee-Jeong Yang; Joel N Bixler; Ying Kong; Jeffrey D Cirillo; Kristen C Maitland
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.